Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 40 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Keyword is Metabolic Syndrome X  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anagnostis, P., Katsiki N., Adamidou F., Athyros V. G., Karagiannis A., Kita M., et al. (2013).  11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?. Metabolism. 62(1), 21-33.
Anagnostis, P., Athyros V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2009).  Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.. J Clin Endocrinol Metab. 94(8), 2692-701.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2014).  Are statins 'IDEAL' for non-alcoholic fatty liver disease?. Curr Med Res Opin. 30(2), 229-31.
Athyros, V. G., Karagiannis A., Ganotakis E. S., Paletas K., Nicolaou V., Bacharoudis G., et al. (2011).  Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.. Curr Med Res Opin. 27(8), 1659-68.
Athyros, V. G., Elisaf M. S., Alexandrides T., Achimastos A., Ganotakis E., Bilianou E., et al. (2012).  Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.. Angiology. 63(5), 358-66.
Athyros, V. G., Ganotakis E. S., Tziomalos K., Papageorgiou A. A., Anagnostis P., Griva T., et al. (2010).  Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.. Curr Med Res Opin. 26(3), 713-9.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2011).  Cardiovascular benefits of bariatric surgery in morbidly obese patients.. Obes Rev. 12(7), 515-24.
Athyros, V. G., Karagiannis A., Hatzitolios A. I., Paletas K., Savopoulos C., Giannoglou G., et al. (2009).  Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study.. Curr Med Res Opin. 25(4), 971-80.
C
Chimonas, T., Karagiannis A., Athyros V. G., Achimastos A., Elisaf M., & Panagiotakos D. B. (2010).  Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis.. Metab Syndr Relat Disord. 8(6), 523-9.
Chimonas, T., Athyros V. G., Ganotakis E., Nicolaou V., Panagiotakos D. B., Mikhailidis D. P., et al. (2010).  Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome.. Angiology. 61(1), 49-57.
G
Galli-Tsinopoulou, A., Grammatikopoulou M. G., Stylianou C., Emmanouilidou E., & Kokka P. (2010).  Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese.. J Endocrinol Invest. 33(8), 549-53.
Gavriilaki, E., Gkaliagkousi E., Nikolaidou B., & Douma S. (2013).  Does vitamin D really contribute to excess cardiovascular risk in rheumatoid arthritis? Comment on the article by Haque et al.. Arthritis Care Res (Hoboken). 65(7), 1203.
Gouveri, E., Papanas N., Hatzitolios A. I., & Maltezos E. (2011).  Breastfeeding and diabetes.. Curr Diabetes Rev. 7(2), 135-42.
H
Hadjistavri, L. S., Sarafidis P. A., Georgianos P. I., Tziolas I. M., Aroditis C. P., Hitoglou-Makedou A., et al. (2010).  Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile.. Med Sci Monit. 16(6), CR307-312.
K
Karamouzis, I., Pervanidou P., Berardelli R., Iliadis S., Papassotiriou I., Karamouzis M., et al. (2011).  Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome.. Horm Metab Res. 43(9), 607-13.
Kargiotis, K., Katsiki N., Athyros V. G., Giouleme O., Patsiaoura K., Katsiki E., et al. (2014).  Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report.. Curr Vasc Pharmacol. 12(3), 505-11.
Kargiotis, K., Athyros V. G., Giouleme O., Katsiki N., Katsiki E., Anagnostis P., et al. (2015).  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.. World J Gastroenterol. 21(25), 7860-8.
Katsiki, N., Athyros V. G., Karagiannis A., Wierzbicki A. S., & Mikhailidis D. P. (2014).  Should we expand the concept of coronary heart disease equivalents?. Curr Opin Cardiol. 29(4), 389-95.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.. Curr Vasc Pharmacol. 12(4), 627-41.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome.. Expert Opin Pharmacother. 13(2), 287-8; author reply 289-90.
Katsiki, N., Mikhailidis D. P., Athyros V. G., & Karagiannis A. (2011).  Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance.. Circ J. 75(8), 2027; author reply 2028.
Katsiki, N., Athyros V. G., & Karagiannis A. (2014).  Metabolic syndrome in clinical practice.. Cardiol J. 21(2), 209.
Konstantinou, D. M., Chatzizisis Y. S., Louridas G. E., & Giannoglou G. D. (2010).  Metabolic syndrome and angiographic coronary artery disease prevalence in association with the Framingham risk score.. Metab Syndr Relat Disord. 8(3), 201-8.
Koumaras, C., Katsiki N., Athyros V. G., & Karagiannis A. (2013).  Metabolic syndrome and arterial stiffness: the past, the present and the future.. J Cardiovasc Med (Hagerstown). 14(10), 687-9.
L
Lazich, I., Sarafidis P., de Guzman E., Patel A., Oliva R., & Bakris G. (2012).  Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.. Diabetes Obes Metab. 14(2), 181-6.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές